BioNTech Stock Price Surges in 2021, up over 330% Ahead of Q2 2021 Earnings

BioNTech keeps posting new highs in 2021. Buyers are not afraid of owning a biotechnology company best known for its contribution to the development of the COVID-19 vaccine.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.